Rainer Boer

1.0k total citations
29 papers, 900 citations indexed

About

Rainer Boer is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, Rainer Boer has authored 29 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Physiology and 8 papers in Biochemistry. Recurrent topics in Rainer Boer's work include Nitric Oxide and Endothelin Effects (9 papers), Eicosanoids and Hypertension Pharmacology (8 papers) and Neuroendocrine regulation and behavior (7 papers). Rainer Boer is often cited by papers focused on Nitric Oxide and Endothelin Effects (9 papers), Eicosanoids and Hypertension Pharmacology (8 papers) and Neuroendocrine regulation and behavior (7 papers). Rainer Boer collaborates with scholars based in Germany, Austria and Poland. Rainer Boer's co-authors include Wolf‐Rüdiger Ulrich, Christian Schudt, Hartmut Glossmann, Alfred Grassegger, Falk Fahrenholz, Thomas Klein, Sabine Haas, Andreas Strub, Christian Heßlinger and Martin D. Lehner and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and The American Journal of Cardiology.

In The Last Decade

Rainer Boer

28 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rainer Boer Germany	17	444	218	162	146	136	29	900
B Berthon France	23	964 2.2×	265 1.2×	356 2.2×	240 1.6×	81 0.6×	39	1.7k
M. E. Parsons United Kingdom	12	427 1.0×	163 0.7×	175 1.1×	66 0.5×	65 0.5×	22	909
Aaron S. Goetz United States	18	1.1k 2.5×	252 1.2×	398 2.5×	94 0.6×	28 0.2×	26	1.8k
Norbert Kolassa Germany	20	629 1.4×	147 0.7×	220 1.4×	123 0.8×	24 0.2×	54	1.3k
James Ziogas Australia	21	750 1.7×	200 0.9×	331 2.0×	91 0.6×	29 0.2×	60	1.5k
Stephen A. Ballard United Kingdom	15	493 1.1×	135 0.6×	82 0.5×	42 0.3×	31 0.2×	26	1.4k
James W. Aiken United States	19	350 0.8×	254 1.2×	187 1.2×	48 0.3×	36 0.3×	26	1.4k
S. Lieberman United States	23	557 1.3×	136 0.6×	129 0.8×	30 0.2×	36 0.3×	42	1.6k
Youichi Yabuuchi Japan	18	544 1.2×	127 0.6×	132 0.8×	44 0.3×	396 2.9×	62	1.4k
Masaaki Tomoi Japan	16	283 0.6×	162 0.7×	118 0.7×	55 0.4×	21 0.2×	39	764

Countries citing papers authored by Rainer Boer

Since Specialization

Citations

This map shows the geographic impact of Rainer Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Boer more than expected).

Fields of papers citing papers by Rainer Boer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Boer. The network helps show where Rainer Boer may publish in the future.

Co-authorship network of co-authors of Rainer Boer

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer Boer. A scholar is included among the top collaborators of Rainer Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer Boer. Rainer Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Eltze, Tobias, Rainer Boer, Thomas E. Wagner, et al.. (2008). Imidazoquinolinone, Imidazopyridine, and Isoquinolindione Derivatives as Novel and Potent Inhibitors of the Poly(ADP-ribose) Polymerase (PARP): A Comparison with Standard PARP Inhibitors. Molecular Pharmacology. 74(6). 1587–1598. 57 indexed citations

2.

Tiso, Mauro, et al.. (2008). BYK191023 (2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine) Is an NADPH- and Time-Dependent Irreversible Inhibitor of Inducible Nitric-Oxide Synthase. Molecular Pharmacology. 73(4). 1244–1253. 8 indexed citations

3.

Heßlinger, Christian, Martin D. Lehner, Andreas Strub, et al.. (2008). O66. The highly selective iNOS inhibitor BYK402750 exerts potent anti-inflammatory effects in a mouse model of cigarette smoke-induced inflammation. Nitric Oxide. 19. 35–35. 2 indexed citations

4.

Lehner, Martin D., Degenhard Marx, Rainer Boer, et al.. (2006). In Vivo Characterization of the Novel Imidazopyridine BYK191023 [2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3 H-imidazo[4,5-b]pyridine], a Potent and Highly Selective Inhibitor of Inducible Nitric-Oxide Synthase. Journal of Pharmacology and Experimental Therapeutics. 317(1). 181–187. 11 indexed citations

5.

Strub, Andreas, Wolf‐Rüdiger Ulrich, Christian Heßlinger, et al.. (2005). The Novel Imidazopyridine 2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) Is a Highly Selective Inhibitor of the Inducible Nitric-Oxide Synthase. Molecular Pharmacology. 69(1). 328–337. 32 indexed citations

6.

Borchers, Christoph H., Rainer Boer, Kurt Klemm, et al.. (2002). Characterization of the Dexniguldipine Binding Site in the Multidrug Resistance-Related Transport Protein P-Glycoprotein by Photoaffinity Labeling and Mass Spectrometry. Molecular Pharmacology. 61(6). 1366–1376. 4 indexed citations

7.

Borchers, Christoph H., Rainer Boer, Kurt Klemm, et al.. (2002). Characterization of the Dexniguldipine Binding Site in the Multidrug Resistance-Related Transport Protein P-Glycoprotein by Photoaffinity Labeling and Mass Spectrometry. Molecular Pharmacology. 61(6). 1366–1376. 28 indexed citations

8.

Eltze, Manfrid, Rainer Boer, Martin C. Michel, et al.. (2001). In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic α 1A - vs. α 1B - and α 1D -adrenoceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 363(6). 649–662. 27 indexed citations

9.

Boer, Rainer, et al.. (2000). The Inhibitory Potency and Selectivity of Arginine Substrate Site Nitric-Oxide Synthase Inhibitors Is Solely Determined by Their Affinity toward the Different Isoenzymes. Molecular Pharmacology. 58(5). 1026–1034. 4 indexed citations

10.

Beck, James F., Frank Buchholz, Wolf‐Rüdiger Ulrich, et al.. (1998). Rhodamine 123 efflux modulation in the presence of low or high serum from CD56+ hematopoietic cells or CD34+ leukemic blasts by B9309-068, a newly designed pyridine derivative. Cancer Letters. 129(2). 157–163. 4 indexed citations

11.

Hofmann, Johann, Volker Gekeler, W Ise, et al.. (1995). Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance. Biochemical Pharmacology. 49(5). 603–609. 34 indexed citations

12.

Ferry, David, et al.. (1994). Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells. European Journal of Pharmacology Molecular Pharmacology. 288(1). 105–114. 27 indexed citations

13.

Eltze, Manfrid, et al.. (1990). Stereoselective inhibition of thromboxane‐induced coronary vasoconstriction by 1,4‐dihydropyridine calcium channel antagonists. Chirality. 2(4). 233–240. 29 indexed citations

14.

Jurzak, Mirek, Rainer Boer, G. Fritzsch, Elżbieta Kojro, & Falk Fahrenholz. (1990). Monoclonal antibodies against different epitopes of peptide hormones. European Journal of Biochemistry. 190(1). 45–52. 7 indexed citations

15.

Boer, Rainer, Alfred Grassegger, Christian Schudt, & Hartmut Glossmann. (1989). (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of α1-adrenoceptors. European Journal of Pharmacology Molecular Pharmacology. 172(2). 131–145. 155 indexed citations

16.

Eltze, Manfrid, Rainer Boer, E. Mutschler, & Günter Lambrecht. (1989). Affinity profiles of BTM-1086 and BTM-1041 at muscarinic receptor subtypes and at H1− and α1-receptors. European Journal of Pharmacology. 170(3). 225–234. 6 indexed citations

17.

Graziadei, Ivo, Gerald Zernig, Alfred Grassegger, et al.. (1989). Hydrophobic calcium channel ligands: Methodical problems and their solution. The American Journal of Cardiology. 64(17). I43–I50. 2 indexed citations

18.

Galvan, Martin, Rainer Boer, & Christian Schudt. (1989). Interaction of telenzepine with muscarinic receptors in mammalian sympathetic ganglia. European Journal of Pharmacology. 167(1). 1–10. 14 indexed citations

19.

Graziadei, Ivo, et al.. (1989). Stereoselective binding of niguldipine enantiomers to α1A-adrenoceptors labeled with [3H]5-methyl-urapidil. European Journal of Pharmacology Molecular Pharmacology. 172(4-5). 329–337. 32 indexed citations

20.

Fahrenholz, Falk, et al.. (1985). Photoaffinity labelling of the renal V₂ vasopressin receptor. European Journal of Biochemistry. 152(3). 589–595. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact